VE
About
Vectura Group is a product development company that focuses on the development of pharmaceutical therapies for the treatment of airways-related diseases. This growing market includes asthma and chronic obstructive pulmonary disease (COPD) and is estimated to be worth in excess of $30 billion worldwide.
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 4 investors are based in Chippenham, Wiltshire, United Kingdom.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech
- Location
- Chippenham, UK
Contact Information
Find more investors like Vectura
Search Investors